Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Graft-vs.-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07079150
What this trial is testing

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

Who this might be right for
Hepatitis B, Chronic (CHB)Hepatitis BHepatitis B Virus (HBV)
First Affiliated Hospital Xi'an Jiaotong University 1,500
Large-scale testing (Phase 3)Study completedNCT01241591
What this trial is testing

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 1,101
Not applicableStudy completedNCT01036958
What this trial is testing

Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft-Versus-Host-Disease
National Cancer Institute (NCI) 3
Not applicableStudy completedNCT03916055
What this trial is testing

Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder

Who this might be right for
Tourette's DisorderPersistent (Chronic) Motor or Vocal Tic Disorder
Karolinska Institutet 221
Not applicableEnded earlyNCT00735735
What this trial is testing

Measurement of Substance P in Saliva of Low Back Pain Patients

Who this might be right for
Low Back Pain
Kovacs Foundation 40
Testing effectiveness (Phase 2)Ended earlyNCT02619617
What this trial is testing

Safety and Efficacy Study of SOM230 s.c. in Cluster Headache

Who this might be right for
Cluster Headache - Episodic and Chronic
Novartis Pharmaceuticals 28
Testing effectiveness (Phase 2)Ended earlyNCT01226420
What this trial is testing

Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease

Who this might be right for
Chronic Graft-versus-host Disease
Dana-Farber Cancer Institute 6
Testing effectiveness (Phase 2)Study completedNCT00399308
What this trial is testing

Evaluation of Safety and Activity of Celaderm in Healing Venous Leg Ulcers

Who this might be right for
Leg UlcerVaricose Ulcer
Shire 40
Early research (Phase 1)Study completedNCT01810718
What this trial is testing

Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD

Who this might be right for
Chronic Graft Versus Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 22
Not applicableActive Not RecruitingNCT04431479
What this trial is testing

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

Who this might be right for
Chronic Graft Versus Host Disease
Fred Hutchinson Cancer Center 211
Not applicableStudy completedNCT02991846
What this trial is testing

A Prospective Observational Study for Evaluating CGVHD

Who this might be right for
Chronic Graft-Versus-Host Disease
Gruppo Italiano Trapianto di Midollo Osseo 248
Post-approval studies (Phase 4)Study completedNCT00044720
What this trial is testing

Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

Who this might be right for
Chronic Kidney FailureGraft vs Host DiseaseKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 484
Testing effectiveness (Phase 2)Ended earlyNCT04111497
What this trial is testing

Glasdegib for Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft Versus Host DiseaseFasciitis
Fred Hutchinson Cancer Center 15
Post-approval studies (Phase 4)Study completedNCT06751290
What this trial is testing

The Use of Cyproheptadine in Pediatric Feeding Disorders

Who this might be right for
Pediatric Feeding Disorder, ChronicAvoidant Restrictive Food Intake Disorder
University of Miami 18
Testing effectiveness (Phase 2)WithdrawnNCT00004878
What this trial is testing

Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Not applicableNo Longer AvailableNCT01200017
What this trial is testing

Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+9 more
Christopher Dvorak
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Not applicableStudy completedNCT04674917
What this trial is testing

Effects of Decompression in Patient With Acute vs Chronic Lumbar Radiculopathy

Who this might be right for
Lumbar Radiculopathy
Riphah International University 30
Very early researchActive Not RecruitingNCT03910452
What this trial is testing

Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4
Testing effectiveness (Phase 2)Study completedNCT01789255
What this trial is testing

Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more
National Cancer Institute (NCI) 12
Next Page